P486 Audit of prophylactic vitamin k documentation in university maternity hospital limerick

BackgroundPhytomenadione (Vitamin K1) is given at birth to all neonates for the prevention of Vitamin K Deficiency Bleeding (VKDB) because there is decline in vitamin k after birth. Reasons for decline are lack of intestinal bacteria required to synthesize vitamin K, quick depletion in stores after...

Full description

Saved in:
Bibliographic Details
Published in:Archives of disease in childhood 2019-06, Vol.104 (Suppl 3), p.A347
Main Authors: Ijaz, Aisha, Mohamed, Mohamed, Asghar, Mohammed, Khan, Rizwan, Zia, Mohammed, Asaaf, Niazy Al
Format: Article
Language:English
Subjects:
Birth
Breast milk
Childrens health
Documentation
Evidence
Hospitals
Intensive care
Intestine
Neonatal care
Neonates
Parents
Pediatrics
Placenta
Vitamin deficiency
Vitamin E
Vitamin K
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BackgroundPhytomenadione (Vitamin K1) is given at birth to all neonates for the prevention of Vitamin K Deficiency Bleeding (VKDB) because there is decline in vitamin k after birth. Reasons for decline are lack of intestinal bacteria required to synthesize vitamin K, quick depletion in stores after birth, poor vitamin k transfer across placenta and low vitamin k concentration in breast milk.ObjectivesTo evaluate adherence to the policy for administration of Phytomenadione (Vitamin k) to Neonates and documentation of prophylactic vitamin k, in UMHL.MethodologyThis is a Prospective study, conducted in University Maternity Hospital Limerick, Limerick, Ireland, in postnatal wards and Neonatal Intensive Care Unit (NICU), during the period from 01/08/2017 to 31/08/2017 with exclusion criteria of not including babies born outside hospitalResultsTotal of 50 patients Healthcare records were assessed, 32 in postnatal wards and 18 in NICU. 48(96%) have documented evidence of vitamin K injection. 48 (96%) mothers consented for vitamin k administration; in 29(60%) there was evidence of verbal consent compared to 19 with no evidence of consent. On PNW in 90% prescription date, dose and route were mentioned and 40% parents received information leaflets. In NICU there was 100% documentation of date, dose and route of administration while no parents were give information leaflets.ConclusionThere was a good compliance to the audited policy, in term of number of patients who received vit k but there was a significant deficiency in documentation practice and information giving to parents.
ISSN:0003-9888
1468-2044
DOI:10.1136/archdischild-2019-epa.822